The World Federation of ADHD International Consensus Statement: 2026 Update
Abstract
Background: In the 5 years since the publication of the original ADHD International Consensus Statement, a great deal of new evidence has emerged. This updated consensus statement reflects the current state of the science with respect to ADHD, with a goal of reducing misconceptions and stigma around the disorder. Methods: Studies eligible for inclusion were published between January 1, 2021 and July 1, 2025 and were either: 1) large cohort studies of 2000 or more participants, or 2) meta-analyses of at least 5 studies or 2000 participants in which publication bias was considered. Eligible studies were summarized and consolidated by theme. Manuscript contents were reviewed and approved by 118 authors from 29 countries and 6 continents. Results: Two hundred and fifty empirically-supported statements were generated from these studies, offering readers an up-to-date understanding of the most robust findings in the areas of prevalence, how genes and environmental factors shape ADHD, psychiatric and somatic comorbidities, cognitive and neurological differences among individuals with ADHD, functional outcomes, and treatments for the disorder. Conclusions: Many of the conclusions of the original Consensus Statement are supported, but this update adds important nuance to some findings as a result of more recent evidence. It also highlights a few areas in which the balance of findings has shifted in the last 5 years, providing a transparent overview of the current scientific state of the field.
Related
- Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement
- Reflections on the ESC consensus statement on inflammation in coronary syndromes: From mechanistic certainty to practical cardiology
- Expert Consensus-Based Clinical Practice Guidelines for Care and Weaning Procedures in Tracheostomized ICU Patients after Invasive Mechanical Ventilation: A Joint Statement by the Intensive Care Physiotherapy Society (SKR) and the French Intensive Care Society (SRLF)
- Contributions of World Federation of Neurology Specialty Groups to brain health, with a public health perspective
- Long-acting growth hormone: an updated Growth Hormone Research Society consensus statement
BibTeX
@misc{faraone2026world,
title = {{The World Federation of ADHD International Consensus Statement: 2026 Update}},
author = {Stephen V. Faraone and Alison E. Pritchard and Mark Bellgrove and Jan Buitelaar and Li Yang and Luis Augusto Rohde and Brooke S.G. Molina and David Coghill and Jeffrey H.Newcorn and David W. Goodman},
howpublished = {PsyArXiv},
year = {2026},
month = oct,
doi = {10.31234/osf.io/w5n9t_v1},
url = {https://osf.io/preprints/psyarxiv/w5n9t_v1/},
note = {CC0},
}
RIS
TY - UNPB
TI - The World Federation of ADHD International Consensus Statement: 2026 Update
AU - Stephen V. Faraone
AU - Alison E. Pritchard
AU - Mark Bellgrove
AU - Jan Buitelaar
AU - Li Yang
AU - Luis Augusto Rohde
AU - Brooke S.G. Molina
AU - David Coghill
AU - Jeffrey H.Newcorn
AU - David W. Goodman
PY - 2026
DA - 2026/10/10
PB - PsyArXiv
DO - 10.31234/osf.io/w5n9t_v1
UR - https://osf.io/preprints/psyarxiv/w5n9t_v1/
AB - Background: In the 5 years since the publication of the original ADHD International Consensus Statement, a great deal of new evidence has emerged. This updated consensus statement reflects the current state of the science with respect to ADHD, with a goal of reducing misconceptions and stigma around the disorder. Methods: Studies eligible for inclusion were published between January 1, 2021 and July 1, 2025 and were either: 1) large cohort studies of 2000 or more participants, or 2) meta-analyses of at least 5 studies or 2000 participants in which publication bias was considered. Eligible studies were summarized and consolidated by theme. Manuscript contents were reviewed and approved by 118 authors from 29 countries and 6 continents. Results: Two hundred and fifty empirically-supported statements were generated from these studies, offering readers an up-to-date understanding of the most robust findings in the areas of prevalence, how genes and environmental factors shape ADHD, psychiatric and somatic comorbidities, cognitive and neurological differences among individuals with ADHD, functional outcomes, and treatments for the disorder. Conclusions: Many of the conclusions of the original Consensus Statement are supported, but this update adds important nuance to some findings as a result of more recent evidence. It also highlights a few areas in which the balance of findings has shifted in the last 5 years, providing a transparent overview of the current scientific state of the field.
ER -